Suppression of phosphatidylinositol 3-kinase/Akt signaling pathway is a determinant of the sensitivity to a novel histone deacetylase inhibitor, FK228, in lung adenocarcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/15706421

Download in:

View as

General Info

PMID
15706421